Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

NAA10 Gene (Ogden Syndrome) Genetic Test in UAE | 2,800 AED

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Laboratory.

Premium Logistics: Hospital-Grade Home Collection via Cold-Chain Transport. VIP Mobile Phlebotomy.

Clinical Guidance: Telephonic Post-Test Interpretation with Senior Genetic Counselor.

Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

! Mandatory Pre-requisite: Genetic Counselling & Pedigree Charting before sample collection.

Test Overview & Methodology

The NAA10 Gene (Ogden Syndrome) Next-Generation Sequencing (NGS) test detects pathogenic variants in the NAA10 gene, critical for diagnosing this rare X-linked dysmorphology condition. This advanced genetic test uses high-depth sequencing to identify point mutations, small insertions/deletions, and copy number variants across all coding exons and splice sites.

Feature Our NGS Test Standard Single-Gene Sanger Sequencing
Targeted Gene Coverage All coding exons & splice sites (full NAA10) Limited to selected exons
Methodology NGS with ≥100× mean depth, CNV detection Dideoxy chain-termination
Turnaround Time 3–4 Weeks (express queue available) 4–6 Weeks
Detection Rate >99% for known pathogenic variants ~90% (misses deep intronic/copy number changes)

Physician Insight & Safety Protocols

“As a Consultant Medical Geneticist, I emphasize that a negative NAA10 result does not exclude Ogden syndrome if the clinical phenotype strongly suggests it; variants in regulatory regions or other genes may mimic the condition. This test must be integrated with comprehensive phenotyping and family history — never in isolation. Parental samples may be required to resolve variant phase.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.

Medication Advisory

Do not discontinue any prescribed medication (e.g., antiepileptics, cardiac therapy) without explicit consultation with your managing physician. Genetic testing does not alter ongoing therapeutic regimens.

Safety Exclusion Criteria & Emergency Red Flags

  • Exclusion: Inadequate sample volume, unconsented minors without guardian consent (per Federal Law No. 2 of 2019), non-FTA card samples for dried blood spot, or sample exposure to extreme temperatures.
  • Emergency Alert: If the patient develops severe respiratory distress, cardiac arrhythmia, or intractable seizures (known Ogden syndrome complications), seek immediate emergency care — do not wait for genetic test results.

Patient FAQ & Clinical Guidance

1. What is the purpose of the NAA10 gene test for Ogden syndrome?

This identifies disease-causing mutations in the NAA10 gene to confirm a clinical suspicion of Ogden syndrome, a rare X-linked disorder. The test enables early intervention and tailored surveillance for associated complications.

2. How is the sample collected and what is the turnaround time?

A hospital-grade phlebotomist collects a small blood sample at your home under cold-chain conditions; results are delivered in 3 to 4 weeks. VIP mobile phlebotomy is available daily from 8 AM to 11 PM.

3. What do the results mean for my child’s future health?

A positive result clarifies the diagnosis, enabling early intervention and tailored surveillance for cardiac, neurological, and growth issues typical of Ogden syndrome. A negative result does not completely rule out the condition if clinical signs are strong.

UAE Regulatory & Data Privacy Adherence

All genetic data is protected under the UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Results are released only to authorized physicians after appropriate verification.

Clinical & Logistical Metadata

Test Name NAA10 Gene (Ogden Syndrome) Sequencing – NGS
Price (AED) 2,800
Turnaround Time 3–4 Weeks (express queue available)
Sample Type / Matrix Whole Blood (Peripheral) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available (8 AM to 11 PM daily)
Methodology Used Next-Generation Sequencing (NGS) with ≥100× mean depth, CNV detection
ICD-10-CM Code Q87.8 (Other specified congenital malformation syndromes)
LOINC Code 81247-9 (NAA10 gene mutation analysis in Blood or Tissue by Molecular genetics method)
DHA Facility License & Laboratory Address DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DHA License No. 1143

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians